Survival in patients with tuberculosis infected with HIV. Study of the deaths within the first nine months;Supervivencia en pacientes con tuberculosis infectados por VIH. Estudio de los fallecimientos en los primeros nueve meses de tratamiento

Revista Espanola de Salud Publica

Volumn 73, Issue 5, 1999, Pages 549-562

  Falqués Casanovas, Meritxell ^a,d   Langohr, Klaus ^b   Gómez Melis, Guadalupe ^a   Garcia De Olalla Rizo, Patricia ^c   Jansà López Del Vallado, Josep M ^c   Caylà Buqueras, Joan A ^c  

^a UNIVERSITAT POLITÈCNICA DE CATALUNYA   (Spain)

^b TU DORTMUND UNIVERSITY   (Germany)

^c HOSPITAL CLÍNIC   (Spain)

^d NONE   (Spain)

Author keywords

AIDS; CD4; Survival; Tuberculin test; Tuberculosis

Indexed keywords

ADULT; ARTICLE; DISEASE CONTROL; FEMALE; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETHALITY; MAJOR CLINICAL STUDY; MALE; SURVIVAL TIME; TUBERCULOSIS; TUBERCULOSIS CONTROL; VIRUS TRANSMISSION;

EID: 0032709273     PISSN: 11355727     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1135-57271999000500003     Document Type: Article

References (24)

1. Le point sur l'épidémic de SIDA: Décembre 1998, Onusida. Http://www.unaids.org/unaids/ document epidernio.
2. Hirschel B, Francioli P, Progress and Problems in the fight againts. AIDS. N Engl J Med 1998; 338: 906-908.
3. Palella FJ, Delaney K, Moorman A, Loveless M, Fuhrer J Satten G et al. Declining Morbidity and Mortality among Patients with advanced Human Immunodeficiency Virus Infection. N Engl J Med 1998. 338: 853-860.
4. Macroft A, Vetla S, Benfield TL, Chiesi A, Miller V, Gargalianos P, et al. Changing patterns on mortality across Europe in patients infected with HIV-1. Lancet 1998; 352: 1725-1730.
5. Macroft A, Johnson M, Phillips A. Factors affecting survival in patients with the acquired immunodeficiency syndrome. AIDS 1996: 10; 1057-1065.
6. Garcia de Olalla P, Caylà JA, Brugal MT, Galdós H. Jansá JM, Clos R. Evolución de la mortalidad y supervivencia del SIDA en Barcelona (1981-1997). Med Clin (Barc) (en prensa)
7. Whalen C, Horsburg CR, Hom D, Lahart C, Simberkoff M and Ellner J. Accelerated Course of Human Immunodeficiency Virus. Infection after Tuberculosis. Am J Crit Care Med 1995. 151: 129-135.
8. Centers for Disease Control. Revision of the CDC Surveillance Case Definition for Acquired Immunodeficiency Syndrome. MMWR 1987 36 (Sup lS). 1S-15S.
9. Grupo de trabajo sobre tuberculosis. Consenso Nacional para el control de la Tuberculosis en España. Med Clin (Barc) 1992; 98. 24-31
10. Collet D. Modelling Survival Data in Medical Research. Text in Statistical Sciences. London: Chapman & Hall; 1994.
11. Norissis MJ. SPSS PV - for yhe IBM PC XT AT. Chicago INC; 1986.
12. Epidemiological Graphics Estimation and Testing package (EGRET). Seattle, Washington: Statistics and Epidemiology Research Corporation; 1990.
13. Borrell C, Plasència A, Pasarin M, Ort́un V. Widening social inequalities in mortality: The case of Barceona, a Southern European City. J Epidemiol Community Health 1997; 51: 659-667.
14. Brugal T, Caylà JA, Diez E, Galdos H, Garcia de Olalla P. Jansà JM et al. Un pla de Prevenció i Control de la Sida per a Barcelona, Barcelona: Imprempta Municipal: 1998.
15. Chaisson RE, Clermont HC, Holt EA, Cantave M, Johnson MP and Atkinson J. Six-month supervised intermittent tuberculosis therapy in Haitian patients, with and without HIV infection. Am J Respir Crit Care Med 1996; 26: 1259-60.
16. Mocroft A, Johnson MA, Phillips AN. Factors affecting survival in patients with the acquired immunodeiciency syndrome. AIDS 1996; 10: 1057-65.
17. Whalen C, Okwera A, Johnson J, Vjecha M, Hom D and Wallts R. Predictors of Survival in human Immunodeficiency Virus-infected Patients with Pulmonary Tuberculosis. Am J Respir Crit Care Med 1996; 153: 1977-81.
18. Richter C, Koelemany, Swat BM, Perenboom R, Mwakyusa DH, Oosting J. Predictive markers of survival in HIV-seropositive and HIV-seronegative Tanzanian patients with extrapulmonary tuberculosis, Tuberc Lung Dis 1996; 76: 510-17.
19. Leroy V, Salmi LR, Dupon M, Sentilhes A, Teixer-Mangein J and Dequae L. Progression of Human Immunodeficiency Virus Infection in Patients with tuberculosis Disease. Am J Epidemiol 1997; 145: 293.
20. Caytà JA, Marco A, Bedoya A, Guerrero R, Garcia J and Martin V. Differential characteristics of AIDS Patients with a History of Imprisonment. Int J Epidemiol. 1995, 24: 1188-1196.
21. Carcaba V, Cartón JA, Moris J, Garcia Amorin Z, Garcia Clemente M and Rodriguez Junquera M. Tuberculosis e infección por VIH. Evaluación de 132 casos. Rev Clin Esp 1993; 193: 12-16.
22. Cayla JA. Jansà, Artacoz L Plasènsia A, AIDS-TB Group. Predictors of AIDS in a cohort of HIV-infected patients with pulmonary or pleural tuberculosis. Tuberc Lung Dis 1993; 74: 113-120.
23. Selwyn PA, Alcabes P, Hartel D, et al. Clinical manifestations and predictors of disease preogression in drug users with human immunodeficiency virus infection. The N Engl J Med 1992; 327. 1697-1702.
24. Alwood K, Keuly J, Moore-Rice, Stanton DL, Chailk CP, Chatsson RE Effectiveness of supervised. intermittent tnerapy for tuberculosis in HIV-infected patients. AIDS 1994; 8: 1103-1108.